Pulsenmore Ltd. (PLSM)
NASDAQ: PLSM · Real-Time Price · USD
4.530
+0.040 (0.89%)
At close: May 26, 2026, 4:00 PM EDT
4.275
-0.255 (-5.64%)
After-hours: May 26, 2026, 7:44 PM EDT
Pulsenmore Market Cap
Pulsenmore has a market cap or net worth of $27.66 million as of May 26, 2026. Its market cap has decreased by -36.75% in one year.
Market Cap
27.66M
Enterprise Value
3.89M
1-Year Change
-36.75%
Ranking
Category
Stock Price
$4.53
Market Cap Chart
Since June 15, 2021, Pulsenmore's market cap has decreased from $245.30M to $27.66M, a decrease of -88.72%. That is a compound annual growth rate of -35.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 25, 2026 | 27.46M | -35.55% |
| Dec 31, 2025 | 42.60M | -38.33% |
| Dec 31, 2024 | 69.08M | -29.88% |
| Dec 31, 2023 | 98.52M | -6.42% |
| Dec 29, 2022 | 105.28M | -48.97% |
| Dec 30, 2021 | 206.33M | -15.89% |
| Jun 15, 2021 | 245.30M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Myomo | 40.18M |
| TELA Bio | 39.85M |
| Phaos Technology Holdings (Cayman) Limited | 39.63M |
| Accuray | 36.51M |
| Nortech Systems | 34.18M |
| NeuroOne Medical Technologies | 31.18M |
| Cytosorbents | 28.89M |
| VolitionRx | 24.80M |